XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab

Stock Information for Generation Bio Co.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Generation Bio Co.

XOMA Royalty Declares Quarterly Preferred Stock Dividends
XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements
XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
XOMA Royalty to Present at Investor Conferences in March
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.